Clinical Trials Directory

Trials / Unknown

UnknownNCT03606733

Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders

Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Macular Diseases and Non Infectious Posterior Uveitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Marashi Eye Clinic · Academic / Other
Sex
All
Age
20 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Injection in the Suprachoroidal space has potential of increasing the efficacy of the drug upto six times with direct effect on retinal tissues sparing the crystalline lens and trabecular meshwork.

Detailed description

A custom made 30 gauge needle offering 1000 micron penetration of the sclera at the parsplana with the help of gentle pressure on the sclera will help to inject medication such as triamcinilone or VEGF blockade agents (Ziv aflibercept or Bevacizumab) in the potential Suprachoroidal space which offers direct effect of injected drug on the retina and choroid sparing both crystalline lens, trabecular meshwork and other ocular tissues, hence improving efficacy of the drug upto six times and reduce potential complications such as cataract and glaucoma.

Conditions

Interventions

TypeNameDescription
PROCEDURECustom suorachoroidal needleCustom made Supra Choroidal Space needle

Timeline

Start date
2018-07-01
Primary completion
2019-08-01
Completion
2019-09-01
First posted
2018-07-31
Last updated
2018-10-29

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT03606733. Inclusion in this directory is not an endorsement.